Keywords: TFPI، مهار کننده پروتئین عامل بافت; TF, tissue factor; TFPI, tissue factor pathway inhibitor; EP, electrostatic potential; mTOR, mammalian target of rapamycin; ER stress, reticulum endoplasmic stress; ROS, reactive oxygen speciesAmblyomin-X; TFPI-like; Proteasome inhibitor; Autophagy inhibi
مقالات ISI TFPI، مهار کننده پروتئین عامل بافت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: TFPI، مهار کننده پروتئین عامل بافت; CXCL12/SDF1, C-X-C motif chemokine 12/stromal cell derived factor-1; Ext1, exostosin-1; HS, heparan sulfate; HSPC, hematopoietic stem/progenitor cells; TFPI, tissue factor pathway inhibitor; VCAM1, vascular cell adhesion molecule-1; WT, wild typeExostosin
Keywords: TFPI، مهار کننده پروتئین عامل بافت; 20; 37CLT, clot lysis time; ELISA, enzyme-linked immunosorbent assay; F, factor; PAI-1, plasminogen activator inhibitor-1; Sao2, oxygen saturation; TAFI, thrombin activatable fibrinolysis inhibitor; TFPI, tissue factor pathway inhibitor; vWF, von Willebra
Determinants of acquired activated protein C resistance and D-dimer in breast cancer
Keywords: TFPI، مهار کننده پروتئین عامل بافت; APC, activated protein C; CAT, calibrated automated thrombogram; ETP, endogenous thrombin potential; F, factor; n-APC-sr, normalized APC sensitivity ratio; OR, odds ratio; SD, standard deviation; TF, tissue factor; TFPI, tissue factor pathway inhibitor; V
A Kunitz-type FXa inhibitor affects tumor progression, hypercoagulable state and triggers apoptosis
Keywords: TFPI، مهار کننده پروتئین عامل بافت; Amblyomin-X; Heparin; Antitumor; Apoptosis; Coagulation; Cell cycleLMWHs, low-molecular-weight heparins; UFH, unfractionated heparin; TFPI, tissue factor pathway inhibitor; PT, prothrombin time; APPT, activated partial thromboplastin time; FXa, active Fac
The association of idiopathic recurrent pregnancy loss with polymorphisms in hemostasis-related genes
Keywords: TFPI، مهار کننده پروتئین عامل بافت; RPL, recurrent pregnancy loss; SERPINC1, antithrombin; THBD, thrombomodulin; TFPI, tissue factor pathway inhibitor; ANXA5, annexin A5; APC, activated protein C; SNP, single nucleotide polymorphism; OR, odds ratio; CI, confidence interval; BMI, body mass i
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis
Keywords: TFPI، مهار کننده پروتئین عامل بافت; TFPI, tissue factor pathway inhibitor; TF, tissue factor; CAD, coronary artery disease; ACS, acute coronary syndrome; IS, ischemic stroke; SMC(s), smooth muscle cell(s); AMI, acute myocardial infarction; AP, angina pectoris; EC(s), endothelial cell(s); LD
TFPI resistance related to inherited or acquired protein S deficiency
Keywords: TFPI، مهار کننده پروتئین عامل بافت; TFPI, tissue factor pathway inhibitor; PS, protein S; NR, normalised ratio; dPT, diluted prothrombin time; aPC, activated protein C; PPP, platelet poor plasma; BSA, bovine serum albumin; TF, tissue factor; C4bBP, C4B binding protein; aPTT, activated parti
The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity
Keywords: TFPI، مهار کننده پروتئین عامل بافت; dPT, dilute prothrombin time; FSAP, Factor seven activating protease; FVII, coagulation factor FVII; MI, Marburg I, uPA, urokinase-like plasminogen activator; SNP, single nucleotide polymorphism; TF, tissue factor; TFPI, tissue factor pathway inhibitor; W
Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury: From epithelium to endothelium
Keywords: TFPI، مهار کننده پروتئین عامل بافت; HNE, human neutrophil elastase; PAR, protease activated receptor; MMP, matrix metalloproteinase; TIMP, tissue inhibitors of metalloproteases; PAI-1, plasminogen activator inhibitor type-1; TFPI, tissue factor pathway inhibitor; α1-PI, α1-antitrypsin; SLPI
Plasma factor VII: A potential marker of pre-eclampsia
Keywords: TFPI، مهار کننده پروتئین عامل بافت; P-EC, Pre-eclampsia; TF, Tissue Factor; ELISA, Enzyme-Linked Immunosorbent Assay; F, Factor; TFPI, Tissue Factor Pathway Inhibitor; IQR, Interquartile Ranges; AUC, Area Under the Curve; CI, Confidence Interval; ROC, Relative Operating Characteristic curve
Hemophilic Synovitis: Factor VII and the Potential Role of Extravascular Factor VIIa
Keywords: TFPI، مهار کننده پروتئین عامل بافت; TF, tissue factor; FVIIa, activated Factor VII; rFVIIa, recombinant activated factor VII; EPCR, endothelial protein C receptor; TFPI, tissue factor pathway inhibitor; I.A., intraarticular; I.V., intravenous; AAV, adeno-associated virusFactor VII; Factor V
Cellular sources of tissue factor in endotoxemia and sepsis
Keywords: TFPI، مهار کننده پروتئین عامل بافت; TF, tissue factor; FVII, factor VII; DIC, disseminated intravascular coagulation; LPS, lipopolysaccharide; TAT, thrombin-antithrombin; TFPI, tissue factor pathway inhibitor; ECs, endothelial cellsTissue factor; Cell type; Sepsis; Endotoxemia; Disseminated
Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: Impairment of mechanisms involved in maintaining intervillous blood flow
Keywords: TFPI، مهار کننده پروتئین عامل بافت; PE, preeclampsia; FGR, fetal growth restriction; TF, tissue factor; TFPI, Tissue Factor Pathway Inhibitor; PAI, Plasminogen Activator Inhibitor; AnxV, Annexin V; TM, Thrombomodulin; Ang-1 and 2, Angiopoietin 1 and 2; VEGF, Vascular Endothelial growth Fact
Alternatively spliced isoforms of tissue factor pathway inhibitor
Keywords: TFPI، مهار کننده پروتئین عامل بافت; TF, Tissue factor; TFPI, Tissue factor pathway inhibitor; K1, first Kunitz domain; K2, second Kunitz domain; K3, third Kunitz domain; GPI, glycosylphosphatidylinositolTissue factor pathway inhibitor; Blood coagulation; Alternative splicing; Translational
Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients
Keywords: TFPI، مهار کننده پروتئین عامل بافت; CVD, cardiovascular disease; PD, peritoneal dialysis; DM, diabetes mellitus; TF, tissue factor; TFPI, tissue factor pathway inhibitor; F1 + 2, prothrombin fragment 1 + 2; uPA, urokinase-type plasminogen activator; suPAR, soluble urokinase-type plasminogen
Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy
Keywords: TFPI، مهار کننده پروتئین عامل بافت; TF, tissue factor; TFPI, tissue factor pathway inhibitor; TFPI-2, tissue factor pathway inhibitor-2; SBP, systolic blood pressure; DBP, diastolic blood pressure; SGA, small for gestational age; TBS, Tris-NaCl buffer; H2O2, hydrogen peroxide; BSA, bovine p
Involvement of Heparanase in early pregnancy losses
Keywords: TFPI، مهار کننده پروتئین عامل بافت; TF, tissue factor; TFPI, tissue factor pathway inhibitor; VEGF, vascular endothelial growth factor; HS, heparan sulfate; ECM, extracellular matrix; LCT, loose connective tissue; HUVEC, human umbilical vein endothelial cell; STB, syncytiotrophoblastHeparan
Involvement of heparanase in vaginal and cesarean section deliveries
Keywords: TFPI، مهار کننده پروتئین عامل بافت; TF, tissue factor; TFPI, tissue factor pathway inhibitor; VEGF, vascular endothelial growth factor; HS, heparan sulfate; ECM, extracellular matrix; CS, cesarean section; IUGR, intrauterine growth restriction; LCT, loose connective tissue; HUVEC, human umb
The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes
Keywords: TFPI، مهار کننده پروتئین عامل بافت; APC, allophycocyanin; PE, Phycoerythrin; TF, tissue factor; TFPI, tissue factor pathway inhibitor; PBMCs, peripheral blood mononuclear cells; CAT, calibrated automated thrombogram; LPS, lipopolysaccharide; FVIIa, factor VIIa; FXa, factor Xa; GPI, glycosyl
CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-κB and ERK 1/2 MAPK pathway
Keywords: TFPI، مهار کننده پروتئین عامل بافت; CRP, C-reactive protein; TF, tissue factor; TFPI, tissue factor pathway inhibitor; HUVECs, human umbilical vein endothelial cells; ACS, acute coronary syndrome; HRP, horseradish peroxidase; PVDF, polyvinylidene difluoride; NF-κB, nuclear factor-kappaB; MA
Endothelial cell regulation by phospholipid oxidation products
Keywords: TFPI، مهار کننده پروتئین عامل بافت; HAEC, human aortic EC; IL, interleukin; LPS, lipopolysaccharide; MM-LDL, minimally oxidized LDL; Ox-PAPC, oxidized PAPC; PAPC, 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine; TF, tissue factor; TFPI, tissue factor pathway inhibitor; TFNα, tumor
Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease
Keywords: TFPI، مهار کننده پروتئین عامل بافت; CAT, calibrated automated thrombography; CHD, congenital heart disease; ETP, endogenous thrombin potential; PPP, platelet poor plasma; S.D., standard deviation; TF, lipidated tissue factor; TTP, time to peak; TFPI, tissue factor pathway inhibitor; AT, ant
An unfavorable combination of factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis—a population-based nested case-control study
Keywords: TFPI، مهار کننده پروتئین عامل بافت; FVL, factor V Leiden; BMI, body mass index; MTHFR, methylenetetrahydrofolate reductase; PROC, protein C; TFPI, tissue factor pathway inhibitor; DVT, deep venous thrombosis; AR, attributable risk; AR%, attributable risk proportion; PAR, population attribut